Ascent Wealth Partners LLC Has $8.42 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Ascent Wealth Partners LLC decreased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 32.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,173 shares of the biotechnology company’s stock after selling 6,928 shares during the quarter. Axon Enterprise makes up about 1.1% of Ascent Wealth Partners LLC’s investment portfolio, making the stock its 27th largest position. Ascent Wealth Partners LLC’s holdings in Axon Enterprise were worth $8,423,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also bought and sold shares of AXON. Prestige Wealth Management Group LLC grew its stake in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise in the 4th quarter valued at $40,000. Brooklyn Investment Group bought a new position in Axon Enterprise during the 3rd quarter worth $41,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the 4th quarter worth about $45,000. Finally, Planning Capital Management Corp grew its stake in shares of Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on AXON shares. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 target price on the stock. in a research note on Thursday. TD Cowen started coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target on the stock. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $561.31.

Insiders Place Their Bets

In related news, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 8,711 shares of company stock valued at $5,631,561 in the last ninety days. Corporate insiders own 6.10% of the company’s stock.

Axon Enterprise Price Performance

AXON opened at $513.22 on Friday. The company has a fifty day simple moving average of $619.94 and a 200 day simple moving average of $518.66. The firm has a market cap of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.43 and a beta of 1.05. Axon Enterprise, Inc. has a twelve month low of $265.32 and a twelve month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.